Exane BNP Paribas Ups GSK To Outperform

Symbols: GSK
Share

Analysts at Exane BNP Paribas upgrade GlaxoSmithKline plc (NYSE: GSK) from “neutral” to “outperform.”

GSK shares fell 1.00% to close at $37.75 on Friday.

More Analyst Ratings here


 
 
< Previous
Goldman Upgrades Lonmin To Neutral
Next >
Sterne Agee Upgrades TFS Financial To Buy, PT At $12
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust